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Post-operative atrial ﬁbrillation (POAF) is the most com-
mon cause of morbidity after coronary surgery, with an
incidence that increases with patient age (1,2). The burdens
of POAF include increased hospitalization stays/costs and
poorer patient prognosis. Patients experiencing POAF have
an increased propensity for adverse coronary events, a greater
incidence of cerebrovascular accidents, and a higher degree
of long-term mortality (3). The incidence of POAF is
particularly problematic for patients with metabolic syn-
drome, which is known to be an independent risk factor for
POAF (4,5).
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Fundamental to the development of new treatments is
gaining new insight into the underlying cause(s) of POAF.
The etiology of arrhythmia is multifactorial, and involves
morphological and electrophysiological changes in cardiac
tissue/cells that promote aberrant conduction. These
changes can be a result of tissue ultrastructure/histology,
inﬂammation, altered expression/activity of sarcolemmal ion
channels, changes in cellular calcium handling, heightened
reactive oxygen species (ROS) production, and/or hetero-
geneity in cardiac action potential duration (3,6). Interest-
ingly, many of these processes are, in some manner,
dependent on the activity of cardiac mitochondria. As the
cellular “hubs” for adenosine triphosphate (ATP) production
and redox homeostasis, mitochondria exert a profound effect
on the electromechanical function of the heart. Whether
poor mitochondrial function is a culprit leading to POAF in
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this paper to disclose.Pre-clinical studies have provided strong evidence that
mitochondrial dysfunction can lead to the development of
arrhythmia. The decrease in mitochondrial energetics, re-
ﬂected by a collapse in mitochondrial membrane potential
(djm) and/or altered mitochondrial respiration, is com-
monly associated with the generation of arrhythmia (6). Loss
of djm precludes adequate regeneration of ATP and
alters the redox environment of the cells. This can induce
action potential heterogeneity via ATP-sensitive and redox-
sensitive modulations of sarcolemmal ion channels, resulting
in the generation of injury currents and subsequent
arrhythmia. Several pre-clinical studies have noted enhanced
collapse of mitochondrial energetics in diabetic hearts, likely
via augmented sensitivity to permeability transition pore
(PTP) opening during conditions of oxidative stress (7,8).
Recent studies examining human heart tissue have
provided insightful translational ﬁndings that corroborate
animal studies. Using permeabilized ﬁbers, several studies
have observed poor mitochondrial function in diseased
human hearts, in particular in patients with metabolic
syndrome (9,10) and heart failure (11,12). Although the
results of these early studies were promising, the sample sizes
were small. Further, a clear link between mitochondrial
dysfunction and arrhythmia has been lacking. Accordingly,
a larger study examining the relationship between mito-
chondrial dysfunction and arrhythmia is needed.
In this issue of the Journal, Montaigne et al. (13) report
their investigation of the relationship between mitochondrial
function and the incidence of POAF in a prospective study.
Using a sample size of >100 patients with metabolic
syndrome, the investigators examined mitochondrial func-
tion in permeabilized cardiac ﬁbers taken before coronary
artery bypass graft surgery. They examined mitochondrial
respiratory function using sequential substrate/inhibitor
titration protocols and determined the activity of speciﬁc
components of the electron transport chain. They also used
different metabolic substrates, providing insight into
substrate-speciﬁc mitochondrial function in their ﬁbers. The
study provides several measures of cellular ROS handling, as
well as insight into gene expression of proteins involved in
cellular energy and redox homeostasis.
Several aspects of the work of Montaigne et al. (13)
represent novel contributions to the ﬁeld. First, they
provide important translational advancement by corrobo-
rating bench-top studies. The observations that the PTP was
more likely to open in hearts that experience postoperative
atrial arrhythmia is an exciting ﬁnding. Opening of this pore
promotes the collapse of djm and can impair cardiac elec-
tromechanical function. Pre-clinical studies have noted that
the generation of arrhythmia occurs commensurate with
collapses in djm (14), although the exact channels/pores
responsible is under debate. Second, animal studies have
suggested that overwhelming the cellular antioxidant defenses
is associated with electrophysiological abnormalities and the
induction of arrhythmia (15,16). Consistent with these
studies, Montaigne et al. (13) found increased ROS levels in
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that these heightened ROS levels occurred despite upregu-
lated manganese superoxide dismutase in POAF patients,
suggestive of a compensatory upregulation of manganese
superoxide dismutase when ROS production is high (17).
In light of the study attributes, several limitations are
worth noting. First are the patient characteristics as assessed
by group means. Patients who experienced POAF had a
slightly higher body mass index ad higher pre-operative
resting heart rates and tended to be older (although this
difference did not quite reach statistical signiﬁcance). Each
of these has previously been independently noted as
a predictor of POAF (1,5,18). To their credit, the authors
performed multivariate regression analyses on each of these
factors, and only higher resting heart rate and impaired
mitochondrial respiration (when ﬁbers were respiring on
fatty acids) were statistically related to POAF.
The authors were also careful to describe the relationship
between mitochondrial dysfunction and arrhythmia as asso-
ciative and not necessarily causal. Although aberrant mito-
chondrial function can certainly drive electrical instability,
a direct relationship is not demonstrated in this study. The
mechanistic knowledge gap between mitochondrial dysfunc-
tion and the generation of arrhythmia still needs to be closed.
The authors have thought of this and allude to the sarco-
lemmal KATP channels (for example) in their discussion. The
actual measurement of these channels, of cellular ATP levels,
mitochondrial membrane potential, or glutathione content
(which exerts a profound inﬂuence on arrhythmia) will
continue to advance our understanding of how mitochondrial
dysfunction is directly linked to POAF.
Accordingly, an interesting question arises from this work
regarding the relationship between POAF and long-term
morbidity/mortality; namely, is POAF directly leading to
adverse events or just a reﬂection/manifestation of unhealthy
tissue mitochondria? Although increased morbidity and
mortality are related to POAF, one cannot help but wonder
whether the POAF is purely symptomatic of poor mito-
chondrial function. This study opens the door for potential
therapies to prevent POAF by targeting mitochondria, but
also suggests that POAF may be a prognosticator for longer
term therapies seeking to sustain mitochondrial function.
Although the isolation and measurement of atrial muscle
ﬁbers are labor intensive, the idea using pre-operative
mitochondrial function as a screening tool for longer term
prognosis is attractive and warrants further investigation.
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